JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 15 November 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01999-06v1
81/3/1390    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guerreiro-Cacais, A. O.
Right arrow Articles by Levitsky, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guerreiro-Cacais, A. O.
Right arrow Articles by Levitsky, V.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01999-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Inhibition of the heavy chain and {beta}2-microglobulin synthesis as a mechanism of MHC class I downregulation during Epstein-Barr virus replication

Andre Ortlieb Guerreiro-Cacais, Mehmet Uzunel, Jelena Levitskaya, and Victor Levitsky*

IRIS Center for Strategic Research, Department of Microbiology, Tumor and Cell Biology, Oncology Pathology Department, Cancer Centrum Karolinska, Karolinska Institutet, Stockholm, Sweden, Department of Clinical Immunology Karolinska University Hospital, Huddinge 141 86 Stockholm

* To whom correspondence should be addressed. Email: Victor.Levitsky{at}ki.se.


   Abstract

The mechanisms of major histocompatibility complex (MHC) class I downregulation during Epstein-Barr virus (EBV) replication are not well characterized. Here we show that in several cell lines infected with a recombinant EBV strain encoding for the green fluorescence protein (GFP), virus lytic cycle coincides with GFP expression, which thus can be used as a marker of virus replication. EBV replication resulted in downregulation of MHC class II and all classical MHC class I alleles independently of viral DNA replication or late gene expression. Although assembled MHC class I complexes, total pool of heavy chains and {beta}2-microglobulin were significantly downreagulated, free class I heavy chains were stabilized at the surface of cell replicating EBV. Calnexin expression was increased in GFP+ cells and calnexin and calreticulin accumulated at the cell surface that could contribute to the stabilization of class I heavy chains. Decreased expression levels of another chaperone ERp57 and TAP2, a transporter associated with antigen processing and presentation, correlated with delayed kinetics of MHC class I maturation. Levels of both class I heavy chain and {beta}2m mRNA were reduced and metabolic labelling experiments demonstrated a very low rate of class I heavy chains synthesis in lytically infected cells. MHC class I and class II downregulation were mimicked by pharmacological inhibition of protein synthesis in latently infected cells. Our data suggest that although several mechanisms may contribute to MHC class I downregulation in the course of EBV replication, inhibition of MHC class I synthesis plays the primary role in the process.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.